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Abstract 
Purpose: To evaluate the growth of the composite corium (constructed with fibroblast cells and gelatin-
co-Bletillastriata gelatin/Salvia miltiorrhiza materials) on rats. 
Methods: The composite artificial corium was constructed by culturing fibroblast cells in gelatin-co-
Bletillastriata gelatin/Salvia miltiorrhiza materials. Full-thickness area of skin was excised from the mice 
and subsequently, the composite corium was transplanted on the wound. Thereafter, the growth 
difference of the composite artificial corium and natural corium were compared. In addition, real-time 
fluorogenic reverse transcription polymerase chain reaction (qRT-PCR) and western blot were 
performed to determine vascular endothelial growth factor (VEGF) expression at gene and protein 
levels. 
Results: The composite artificial corium showed significant repair promoting effect on the skin, and the 
structure of the repaired skin was similar to that of natural corium. Interestingly, PCR and western blot 
results showed that the expressions of VEGF were higher in composite artificial corium than in natural 
corium on days 3 and 7 post-transplantation. 
Conclusion: The composite artificial corium has some clinical prospects for use in the treatment of 
wounds on large areas of skin. 
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Skin, the largest organ of human being, plays a 
vital role as a barrier against infection, hurt and 
loss of water and electrolytes, etc. [1]. In recent 
years, large areas of skin and soft tissue defects 
have been increasingly occurring in trauma and 
burns, and treatment of large areas of skin 
defects have become a significant problem clinic 
[2,3]. Currently, the main strategy for treating 
skin defect is autologous skin grafts, and 
however the autologous skin is limited, especially 
for children [3]. Thus, it is important and 
necessary to find more ways to treat large areas 
of skin defects.  
 
Recently, tissue engineering advancements have 
improved the understanding of wound healing 
and strategy for skin repair and regeneration [3-
5]. The tissue engineered dermal equivalent 
could be constructed with fibroblasts and 
biocompatible scaffold [5]. Previous 
investigations have reported that gelatin and 
bletilla striata gelatin are good film-forming 
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materials, which could be made into scaffold. 
Salvia miltiorrhiza can promote tissue repair and 
growth of wound granulation tissue via promoting 
the expression of endogenous epidermal growth 
factor (EGF), fibroblast growth factor (bFGF), 
vascular endothelial growth factor (VEGF), 
transforming growth factor-β1 (TGF-β1), and 
insulin-like growth factor 1 (IGF-1) [6]. In 
addition, the essence of granulation tissues is 
capillaries and fibroblasts, and therefore the 
Salvia miltiorrhiza has a good ability to promote 
angiogenesis. 
 
In this study, by using freeze-drying the porous 
scaffold was prepared with raw materials of 
gelatin, bletilla striata gelatin and Salvia 
miltiorrhiza. Then, the artificial corium was 
constructed by adding fibroblasts into the 
prepared porous scaffold. Subsequently, in order 
to explore the feasibility of the composed corium 
in the clinic for treating large area of skin defect, 





Materials and chemicals 
 
Gelatin was purchased from the Chinese 
Medicine Group Chemical Reagent Co., Ltd. 
(Shanghai, China); Bletilla striata gelatin and 
Salvia miltiorrhiza extracts were obtained from 
the Pharmaceutical laboratory of Hubei 
University of TCM (Wuhan, China); the 
composite corium was constructed by culturing 
fibroblast cells in gelatin-co-Bletilla striata 
gelatin/Salvia miltiorrhiza materials. Trizol 
Reagents were purchased from Invitrogen 
Biotech. Co. (Shanghai, China); VEGF and β-
actin antibodies were purchased from Santa 
Cruz Biotechnology (Shanghai, China). All other 
chemicals used in our study were analytical 
reagent grade. 
 
Animals and grouping 
 
Male SD rats (220-260 g) were purchased from 
the Animal center of Medical College of Wuhan 
University (Wuhan, China). A total of 45 SD rats 
were randomly divided into three groups (n=15), 
including two experimental groups (group 1 was 
natural corium and group 2 was artificial corium) 
and a control group (group 3). All animal 
experiments in the study were in accordance with 
the National Institute of Health Guide for the 
Care and Use of Laboratory Animals, and all the 
experimental protocols were approved by the 
Animal Care and Use Committee of the Renmin 





After intraperitoneal injection (ip) of sodium 
pentobarbital (40 mg/kg), the rats were 
anesthetized and fixed. Routine disinfection and 
skin preparation was performed and then a 3 × 3 
cm section of skin was dissected from the back 
of each animal and placed in saline. In the 
natural corium group, the skin graft was then 
covered and stitched in situ; in the artificial 
corium group, the subcutaneous tissue, including 
the deep fascia, were completely stripped and a 
2 × 2 × 0.2 cm artificial dermis graft was placed 
on the wound prior to an autologous skin graft, 
which was then covered and stitched; in the 
control group, the subcutaneous tissue, including 
the deep fascia, were completely stripped, but 
only an autologous skin graft was placed on the 
wound, which was then covered and stitched. 
Sample collection was made at 3, 7, 14, 28 and 
56 day after surgery, whereby three rats were 
sacrificed in each group and wound healing was 
observed. In the control and natural corium 
group, full-thickness skin tissues at the surgical 
sites were harvested; in the artificial corium 
group, full-thickness skin tissue and the artificial 
dermis implanted at the wound site were 
collected. The samples were subjected to 
hematoxylin and eosin (HE) staining. The 
expression of VEGF gene was detected by RT-
PCR in samples collected from days 3 and 7, 
and the samples collected on day 7 were also 
used to detect the expression of the VEGF4 
protein. 
 
HE staining assay 
 
The tissue samples were fixed with freshly 
prepared 4 % formaldehyde in phosphate-
buffered saline (PBS) at room temperature for 4 
h and were then washed in PBS three times for 
60 min. Then, alcohol gradient dehydration was 
performed, subsequently embedded with 
paraffin. Then, tissue sections (5 μm thick) were 
prepared with H&E straining, according to the 
reported methods [7]. The histopathological 
changes were observed using a microscope 
(Olympus, Japan). 
 
Real-time fluorogenic PCR assay 
 
Tissues were collected, and total RNA was 
extracted using Trizol reagent. Total RNA was 
used for cDNA synthesis of VEGF and β-actin by 
reverse transcription using quantitative real-time 
PCR. All mRNA primers were designed by 
Primer Premier 5.0 and shown in Table 1. 
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Reverse transcription was carried out according 
to instruction of the TOYOBO quantitative real-
time RT-PCR reaction kits (Osaka, Japan). 
 
Western blot analysis 
 
VEGF protein expression was detected using 
western blot assay. Briefly, the tissues samples 
were collected, and total proteins were extracted. 
Then, protein concentration was determined 
using a BCA regent kit (Beyotime Biotech, 
Haimen, China). Then, 30 μg proteins were 
loaded onto sodium dodecyl sulfate-
polyacrylamide gel for electrophoresis (SDS-
PAGE) and blotted onto poly-vinylidene difluoride 
membrane (PVDF). Subsequently, VEGF and β-
actin primary antibodies were used to determine 
protein expression at 4 °C for 12 h, followed by 
the secondary antibodies (HPR, Beyotime 
Biotech, Haimen, China). Finally, the immuno 
reactive bands were visualized with ECL-




All data were expressed as the mean ± standard 
deviation (SD) and analyzed with one-way 
analysis of variance (ANOVA) with statistical 







As shown in Figure 1, wound healing was 
consistent with the conventional healing process 
in the natural corium group. At 7 days after 
transplantation, there was no visible abscess, 
exudation or other abnormal reaction (Fig 1B). At 
14 days after transplantation, the edge of the 
wound became blurred and hair growth was 
observed (Fig 1C). At 28 days after 
transplantation, the surgical site appeared similar 
to normal tissue (Fig 1D). The same as that of 
rats in the natural corium group, there was no 
abscess, exudation or other abnormal reaction 
after 7 days transplantation in the artificial corium 
group. After 14 days of the transplantation, the 
grafts appeared normal with the exception of one 
rat, where skin graft necrosis was observed.  
 
Notably, the edge of the wound appeared blurred 
and wound healing appeared to have proceeded 
adequately (Figure 1E). At 28 days after 
transplantation, wound contraction occurred, and 
a small amount of hair growth was observed. 
After 56 days, the grafts were still functional, and 
a small piece of graft was observed to have 
ischemic necrosis and was subsequently 
replaced by the surrounding skin. Compared to 
the control group, the color of the graft in the 
artificial corium group was light and the re-
growing hair was shorter. 
 
In the control group, significant dry shrinkage of 
the skin graft had occurred at 7 days after 
transplantation, and the wound edges of the 
remaining seven rats were significantly dark and 
gloomy. After 14 days of transplantation, grafts 
became dark, and at 28 days after 
transplantation, only four rats had functional skin 




Seven days after surgery, HE staining in the 
artificial corium group showed that inflammatory 
cells had infiltrated the artificial dermis, and new 
capillaries were observed and many fibroblasts 
were noted to be growing on the scaffold. 
Fourteen days after surgery, the porous scaffold 
was completely surrounded by tissue, fibroblasts 
were growing steadily and the new blood 
capillaries were confluent (Fig 2A). At day 28, the 
material had been completely absorbed and 
many new collagen fibers with irregular 
arrangements were in place, the neo-vasculature 
was more mature and wound contraction was 
observed (Fig 2B). At day 56, the structure of the 
skin was similar to normal rats, but lacked hair 
follicles and sweat glands, and there was a gap 





RT-PCR results showed that the VEGF gene 
was expressed in damaged tissues and the 
expression of VEGF was significantly higher in 
the natural and artificial groups than that in 
control group at 3 days after transplantation. The  
 
Table 1: Primers used for PCR 
 
Variable Sequence (5′-3′) Length  
VEGF TGTGAGCCTTGTTCAGAGCG 252bp GACGGTGACGATGGTGGTGT 
β-actin CGTTGACATCCGTAAAGACCTC 110bp TAGGAGCCAGGGCAGTAATCT 
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Figure 1: Results of the wound healing. A. Derma transplantation; B.7 days after transplantation in natural 
corium group. C. 14 days after transplantation in natural corium group; D. 28 days after transplantation in natural 




Figure 2: Results of the HE staining assay. A. At 14 days after transplantation in artificial corium group; B. At 28 
days after transplantation inartificial corium group; C. At 56 days after transplantation inartificial corium group; D. 
At 56 days after transplantation in control group 
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        Figure 3: VEGR expressions 
 
 
Figure 4: VEGF expression by western blot assay. To normalize for protein loading, VEGF expression level was 
expressed as a relative value to that of β-actin 
 
expression level decreased on the 7th day 
compared to the 3rd day (Figure 3). In general, 
the expressions of VEGF in rats that received the 
artificial dermis were lower than that of rats in the 
natural dermis group. 
 
As can be seen from Figure 4, our western blot 
assay results showed that VEGF expressions in 
the two experimental groups were significant 
higher than that in the control group (p < 0.01). 
However, our results also indicated that the 
expression of the VEGF protein in the artificial 





Skin tissue engineering uses modern biology and 
engineering principles to construct tissue 
substitutes for damaged tissues [8]. Artificial skin 
has been successfully used to repair large areas 
of defective skin resulting from trauma or burns 
[9,10]. However, artificial skin suffers from a 
number of disadvantages. For example, since 
only a layer of the epithelia is covered on the 
wound, the surviving epithelial tissues, with poor 
elasticity, can easily break and contract. 
Previously, histology has shown that the 
epithelial basement membrane contains 
incomplete collagen fibers and anchors [11]. 
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Therefore, research has focused on better 
dermal substitutes [12]. 
 
In this regard, researchers found that the addition 
of β-FGF to the artificial dermis could accelerate 
tissue regeneration [13]. 
 
Meanwhile, Wilcke et al found that incorporation 
of VEGF and β-FGF into fibrin matrix materials 
could result in the construction of dermal 
substitutes, which could accelerate the formation 
of new blood vessels and improve graft survival 
when replanted into the full-thickness skin 
wounds of nude mice [14]. Furthermore, 
Pienimaki et al [15] found that EGF could 
significantly accelerate wound healing and 
promote keratinocytes to produce hyaluronan 
and Cuono et al [16] constructed a 
deepidermalized dermis (DED) with cadaver 
skin, which retained the scaffold and full 
basement membrane complex without 
immunogenicity, and the epidermal cells could 
differentiate into a multilayered epidermis on the 
DED. Hansbrough et al [17] cultured fibroblasts 
on poly glycolic acid (PGA) fibers in vitro for 2-3 
weeks and then used it to repair a skin wound. 
They found that new blood vessels formed, 
fibroblasts proliferated and a collagen matrix 
formed. 
 
In order to accelerate vascular formation and 
wound healing, many studies have been 
performed in which angiogenic drugs and 
fibroblast culture have been used and shown to 
be applicable techniques. Coulommb et al [18] 
constructed a dermal substitute with fibroblasts 
and collagen gel, and then transplanted the 
dermis onto rats. The results showed that the 
fibroblasts grew and proliferated on the wound. 
Meanwhile, Yamada et al [19] treated 26 wound 
sites with a fibroblast-cultured collagen sponge 
and the results showed that wound healing was 
significantly accelerated. 
 
In our study, fibroblasts were cultured on a 
gelatin-co-Bletilla striata gelatin/Salvia 
miltiorrhiza composite to construct an artificial 
dermis, which was then transplanted onto the 
dermis of rats. The results showed that the 
artificial dermis integrated into the skin graft after 
7 days, and there was obvious dermis-like tissue 
formation after 14 days. Furthermore, the 
artificial materials were absorbed and the 
artificial skin began to replace the defective skin 
after 28 days. On day 56, the resulting dermal 
structure appeared similar to normal skin. VEGF 
is the most important factor in wound healing 
[20,21] and is expressed approximately 1 day 
after skin injury, reaching a peak after 3–4 days. 
Its levels finally return to normal after 10 – 14 
days [22]. Therefore, the expressions of the 
VEGF gene and protein were detected to assess 
wound healing. The results showed that the 
expression of VEGF was significantly high in the 
artificial dermis and natural dermis groups after 3 




The developed gelatin-co-Bletilla striata 
gelatin/Salvia miltiorrhiza composite may be 
applied as a dermal substitute to promote 
vascularization of damaged skin tissue. 
However, the composite still needs to be further 
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